Effect of drug compliance on health care costs in newly-diagnosed dementia: Analysis of nationwide population-based data

ConclusionsThis population-based retrospective cohort study provides evidence that patients newly-diagnosed with dementia who showed higher initial drug compliance or maintained antidementia drugs (Cholinesterase inhibitors and memantine) would benefit in total health-care costs.
Source: Journal of Psychiatric Research - Category: Psychiatry Source Type: research